Blackstone Inc’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-13,033
| Closed | -$16.2K | – | 171 |
|
|
2024
Q1 | $16.2K | Hold |
13,033
| – | – | ﹤0.01% | 171 |
|
|
2023
Q4 | $13.7K | Sell |
13,033
-1,248,392
| -99% | -$1.31M | ﹤0.01% | 157 |
|
|
2023
Q3 | $8.64M | Buy |
1,261,425
+1,248,392
| +9,579% | +$8.55M | 0.04% | 81 |
|
|
2023
Q2 | $135K | Hold |
13,033
| – | – | ﹤0.01% | 143 |
|
|
2023
Q1 | $105K | Hold |
13,033
| – | – | ﹤0.01% | 154 |
|
|
2022
Q4 | $205K | Hold |
13,033
| – | – | ﹤0.01% | 152 |
|
|
2022
Q3 | $205K | Hold |
13,033
| – | – | ﹤0.01% | 191 |
|
|
2022
Q2 | $182K | Hold |
13,033
| – | – | ﹤0.01% | 222 |
|
|
2022
Q1 | $225K | Hold |
13,033
| – | – | ﹤0.01% | 213 |
|
|
2021
Q4 | $189K | Buy |
+13,033
| New | +$189K | ﹤0.01% | 386 |
|